Specialties

In this exclusive interview, Dr. Claude Lardinois discusses genetic risk factors for cardiovascular issues in diabetes patients, the impact of smoking on amputations, and why albumin is a driver of cardiovascular disease.

In part 2 of this exclusive interview from AACE 2016, Dr. Claude Lardinois discusses why albumin is a driver of cardiovascular disease.

Job insecurity found to prompt 19% increase in diabetes, myocardial infarction or coronary death risk.

Female, 76 years of age, type 2 diabetes, well managed, A1C 6%, on metformin 500mg daily. Patient also has well-managed hypertension, hyperlipidemia, and osteoporosis. She lives alone. Wants tighter diabetes control. Was having hypoglycemia when on 500mg twice daily. Requests, almost begs me, to increase her medication. States she’s afraid she’s going to have kidney problems.

Device automatically monitors blood glucose levels and delivers insulin when appropriate for people age 14 years and older who have type 1 diabetes.

Semaglutide reduced major cardiovascular events by 26% in adults with type 2 at high cardiovascular risk.

Patients treated for cholesterol lowering appear to have extra benefits.

Research reveals important gaps in care.

In part 2 of this exclusive ADA interview, Anthony Cincotta discusses the Cycloset Safety Trial study design and findings regarding the cardiovascular safety of Cycloset.

In part 1 of this exclusive ADA interview, Anthony Cincotta discusses the mechanistic science behind the development of Cycloset, and why preclinical and clinical findings suggest the therapy may reset clock mechanisms governing postprandial glucose metabolism.